News
The CDC already recommends the RSV shot for all adults 75 and older and for people 60 and older who have health conditions that increase their risk of severe RSV. It also recommends the shot during ...
Respiratory syncytial virus (RSV) infections were associated with significantly increased risk for complications beyond ...
Child mortality has been halved in the last 25 years. Building on this progress, new innovations in immunization are working ...
The over-75s and anyone 28 weeks pregnant or more are eligible for a free vaccine. These groups qualify for an RSV vaccine, ...
The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...
The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
Explore more
Shares of Moderna (NASDAQ:MRNA) have been long forgotten about since its demand for COVID shots fell off a cliff more than ...
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...
The medicines regulator has flagged up a small increased risk of Guillain-Barré syndrome after RSV vaccination in adults over ...
New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...
Adults as young as 50 may now qualify for an RSV vaccine if they have certain health conditions, according to a quiet update from the U.S. Centers for Disease Control and Prevention (CDC).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results